Ethnicity Lemborexant

2 source-based articles maintained by the HealthRX.com Editorial Team.

2articles

2topic areas covered

Jan 28, 2025latest review

Ethnicity Lemborexant library

Showing 2 of 2 clinical reviews.

Dosing & MonitoringJan 28, 2025

Dayvigo (Lemborexant) Dosing in Black and African Ancestry Patients: What the Evidence Actually Shows

A clinician-facing review of lemborexant pharmacogenomics, SUNRISE trial subgroup data, and practical dose-adjustment guidance for patients of Black or African ancestry.

Clinical ReviewsMay 27, 2026

Dayvigo (Lemborexant) in South Asian Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations

South Asian patients may respond differently to lemborexant (Dayvigo) due to CYP3A4 polymorphisms, body composition differences, and underrepresentation in key trials. This article reviews available ethnicity-stratified data, pharmacogenomic factors, and practical dosing guidance.